These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27788887)

  • 1. Tolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria.
    Walters KM; White AA
    Ann Allergy Asthma Immunol; 2016 Nov; 117(5):559-561. PubMed ID: 27788887
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice.
    Bongiorno MR; Crimi N; Corrao S; Allotta A; Arena A; Brusca I; Heffler E; Malara G; Milioto M; Pistone G; Porto M; Raia E; Valenti G
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):703-707. PubMed ID: 27720581
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.
    Leiva-Salinas M; Francés L; Marin-Cabanas I; Arribas Granados MP; Silvestre JF
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):1027-8. PubMed ID: 24629127
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic Idiopathic Urticaria.
    Wu EY; Saini SS
    J Allergy Clin Immunol Pract; 2015; 3(6):1003-4; quiz 105. PubMed ID: 26553623
    [No Abstract]   [Full Text] [Related]  

  • 5. IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria.
    Cugno M; Genovese G; Ferrucci S; Casazza G; Asero R; Marzano AV
    Br J Dermatol; 2018 Sep; 179(3):776-777. PubMed ID: 29582427
    [No Abstract]   [Full Text] [Related]  

  • 6. Home self-administration of omalizumab for chronic spontaneous urticaria.
    Denman S; Ford K; Toolan J; Mistry A; Corps C; Wood P; Savic S
    Br J Dermatol; 2016 Dec; 175(6):1405-1407. PubMed ID: 27639259
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of omalizumab in the treatment of chronic urticaria.
    Cordeiro Moreira AS; Rosmaninho Lopes de Soares E Silva MI; Pereira Guilherme MA; da Silva Ferreira JA; Fonseca Moreira da Silva JP
    Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):242-246. PubMed ID: 27852430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic spontaneous urticaria in an 8-year-old girl treated with omalizumab.
    Ossorio-García L; Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Linares-Barrios M
    Clin Exp Dermatol; 2016 Dec; 41(8):929-930. PubMed ID: 27761937
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.
    Ensina LF; de Lacerda AE; Machado LM; Camelo-Nunes I; Solé D
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):536. PubMed ID: 26653279
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.
    Chicharro P; Rodríguez-Jiménez P; de Argila D
    Actas Dermosifiliogr; 2017 May; 108(4):383-384. PubMed ID: 27914623
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab in the treatment of antihistamine-resistant chronic urticaria in adults.
    Gómez-Vera J; Gutiérrez-Ávila SA; Acosta-Gutiérrez DN; López-Tiro JJ; Bedolla-Barajas M
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):204-6. PubMed ID: 27369651
    [No Abstract]   [Full Text] [Related]  

  • 12. Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.
    Casale TB; Win PH; Bernstein JA; Rosén K; Holden M; Iqbal A; Trzaskoma BL; Yang M; Antonova EN; Murphy T; Scarupa MD; Sofen H; Kaplan A
    J Am Acad Dermatol; 2018 Apr; 78(4):793-795. PubMed ID: 29037993
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab.
    Asero R
    Clin Exp Dermatol; 2017 Aug; 42(6):667-669. PubMed ID: 28691309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab-induced triphasic anaphylaxis in a patient with chronic spontaneous urticaria.
    Gönül M; Özenergün Bittacı A; Ergin C
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e135-e136. PubMed ID: 26446412
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.
    Nettis E; Cegolon L; Macchia L; Zaza I; Calogiuri G; Di Leo E
    Acta Derm Venereol; 2018 Apr; 98(4):446-448. PubMed ID: 29362811
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.
    Koski R; Kennedy KK
    Ann Allergy Asthma Immunol; 2017 Nov; 119(5):397-401. PubMed ID: 29150066
    [No Abstract]   [Full Text] [Related]  

  • 17. Omalizumab for the treatment of chronic spontaneous urticaria in daily clinical practice in South Spain.
    Ruiz-Villaverde R; Pereyra-Rodriguez JJ; Hernández-Montoya C; Galán-Gutierrez M; Alcantara-Luna S; Lara-Jimenez MA
    Dermatol Ther; 2018 Sep; 31(5):e12669. PubMed ID: 30063807
    [No Abstract]   [Full Text] [Related]  

  • 18. Omalizumab in An 8-Year-Old Boy With Diabetes Mellitus and Refractory Chronic Spontaneous Urticaria.
    Jesenak M; Ciljakova M; Janickova M; Banovcin P
    J Investig Allergol Clin Immunol; 2019 Apr; 29(2):144-146. PubMed ID: 31017115
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.
    Saini SS; Omachi TA; Trzaskoma B; Hulter HN; Rosén K; Sterba PM; Courneya JP; Lackey A; Chen H
    J Invest Dermatol; 2017 Apr; 137(4):958-961. PubMed ID: 27939380
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.
    Gericke J; Metz M; Ohanyan T; Weller K; Altrichter S; Skov PS; Falkencrone S; Brand J; Kromminga A; Hawro T; Church MK; Maurer M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1059-1061.e1. PubMed ID: 27838346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.